ClinicalTrials.gov record
Completed No phase listed Observational Results available

Registry Study of Revcovi Treatment in Patients With ADA-SCID

ClinicalTrials.gov ID: NCT03878069

Public ClinicalTrials.gov record NCT03878069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (Elapegademase-lvlr) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy

Study identification

NCT ID
NCT03878069
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Chiesi Farmaceutici S.p.A.
Industry
Enrollment
32 participants

Conditions and interventions

Interventions

  • elapegademase-lvlr Biological

Biological

Eligibility (public fields only)

Age range
0 Months to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2019
Primary completion
Jan 17, 2023
Completion
Jan 17, 2023
Last update posted
Nov 14, 2024

2019 – 2023

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
University of California Los Angeles Los Angeles California 90095-1752
Allergy & Asthma Medical Group and Research Center, A P.C. San Diego California 92123
UCSF - University of California San Francisco California 94158
Children's National Washington D.C. District of Columbia 20010
University of South Florida Allergy Immunology Clinic St. Petersburg Florida 33701
Childrens Hospital of New Orleans New Orleans Louisiana 70118
Children's Minnesota Minneapolis Minnesota 55404
St. Louis Children's Hospital - Washington University School of Medicine St Louis Missouri 63110
UBMD Pediatrics Outpatient Center Buffalo New York 14203
Duke University Hospital Durham North Carolina 27705
Penn State Children's Hospital Hershey Pennsylvania 17033
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Le Bonheur Children's Hospital Memphis Tennessee 38105
Seattle Children's Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03878069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2024 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03878069 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →